← FDA Drug Approvals (Drugs@FDA)
ZYNYZ
BLA · Biologics License Application · Sponsor: INCYTE CORP · Approved 2023-03-22
Drug application
- FDA Application #
BLA761334- Application type
- Biologics License Application
- Brand name
- ZYNYZ
- Generic name
- RETIFANLIMAB-DLWR
- Active ingredients
- RETIFANLIMAB-DLWR
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- INCYTE CORP
- Manufacturer
- Incyte Corporation
- First approval
- 2023-03-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown